Ferak Berlin Receives GMP Certification

Thomas Gruendemann, CEO and managing director, Ferak
Thomas Gruendemann, CEO and managing director, Ferak

Berlin, Germany-based provider of contract research & development and custom manufacturing services, Ferak, has received GMP certification by the Berlin State Office for Health and Social Affairs (LAGeSo) for one of its Active Pharmaceutical Ingredients (API). The GMP certificate that has been obtained by help of the Administrative Court of Berlin is immediately available upon request. Prior to the allocation of the certificate an independent GMP expert authorized by the German Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel - BfArM) confirmed full EU-GMP Part II compliance of the manufacturing process and equipment. Further API certificates will follow, the company reports.

“I am more than proud to say that the whole team of Ferak has been working hard to achieve this highest quality standard in the chemical/pharmaceutical industry”, says CEO and managing director Thomas Gruendemann. “The combination of our scientific expertise with both a detailed documentation system and the latest production and analytical equipment is the key to the high purity of our APIs. A clear GMP aim and a zero defect supply chain history with all of our pharmaceutical customers have lead us to this level of excellence which meets exactly our mission statement The Art of Making Purity”, Gruendemann concludes.

Company

Ferak Berlin GmbH

Lahnstr. 34
12055 Berlin
Germany

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 24-25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.